Chronic obstructive pulmonary disease: Signs and symptoms, diagnosis, treatments, lifestyle risk factors and management
PDF

Keywords

Chronic obstructive pulmonary disease
clinical characteristics
health care
lifestyle practices

How to Cite

Lim, S. Y., Ulaganathan, V., Gunasekaran, B. ., Salvamani, S. ., Tiong, Y. L. ., Muhammad Royani, S. M., Silvermany, K. ., Augundhooa, D. ., & Chambari, M. . (2024). Chronic obstructive pulmonary disease: Signs and symptoms, diagnosis, treatments, lifestyle risk factors and management. Life Sciences, Medicine and Biomedicine, 8(1). https://doi.org/10.28916/lsmb.8.1.2024.123

Abstract

Chronic Obstructive Pulmonary Disease (COPD) is associated with increased health complications, leading to a rise in mortality rates. COPD remains a significant global health issue, underscoring the importance of recognizing symptoms, facilitating diagnosis, and implementing effective treatment strategies. However, information on lifestyle risk factors and the management of COPD remains fragmented. This review paper aims to understand the clinical pathophysiologic changes triggered by lifestyle practices and their management strategies. It is important to understand its symptoms, diagnostics criteria, and treatment to correlate with lifestyle risk factors and to identify effective lifestyle interventions. Lifestyle practices as defined by dietary practices such being anorexia and low fruit and vegetable intake, smoking habits, alcohol consumption, and physical inactivity have increased the risk of COPD. This review suggested lifestyle approaches for COPD treatment such as regular exercise, a healthy diet, and avoiding smoking. In this case, the development of the guided improved intervention is important for a better understanding of the mechanisms between COPD and its associated lifestyle practices. This information may help clinicians, health practitioners, and dietitians to guide patients to implement improved dietary interventions. To avoid the progression of COPD, lifestyle practice therapy could be the most effective strategies that aid with medications as prescribed by the physicians.

https://doi.org/10.28916/lsmb.8.1.2024.123
PDF

References

Abdulai, R. M., Jensen, T. J., Patel, N. R., Polkey, M. I., Jansson, P., Celli, B. R., & Rennard, S. I. (2018). Deterioration of limb muscle function during acute exacerbation of chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine, 197(4), 433–449.

https://doi.org/10.1164/rccm.201703-0615CI

Acanfora, D., Scicchitano, P., Carone, M., Acanfora, C., Piscosquito, G., Maestri, R., Zito, A., Dentamaro, I., Longobardi, M., Casucci, G., Antonelli-Incalzi, R., & Ciccone, M. M. (2018). Relative lymphocytes count as an indicator of 3-year mortality in elderly people with severe COPD. BMC Pulmonary Medicine, 18(1), 116.

https://doi.org/10.1186/s12890-018-0685-6

Albarrati, A. M., Gale, N. S., Munnery, M. M., Cockcroft, J. R., & Shale, D. J. (2020). Daily physical activity and related risk factors in COPD. BMC Pulmonary Medicine, 20(1), 60.

https://doi.org/10.1186/s12890-020-1097-y

Amalakanti, S., & Pentakota, M. R. (2016). Pulse oximetry overestimates oxygen saturation in COPD. Respiratory Care, 61(4), 423–427.

https://doi.org/10.4187/respcare.04435

American Academy of Family Physicians. (2016). COPD and Asthma, Differential Diagnosis.

https://www.aafp.org/dam/AAFP/documents/news/COPD-Asthma_Phys_Ed_Booklet.pdf

Ayar Karakoç, G., Ernam, D., Aka Aktürk, Ü., Öztaş, S., Oğur, E., & Kabadayı, F. (2016). The evaluation of nutritional status of stable COPD patients and to investigate the effect of nutritional status on perception of dyspnea, exercise capacity, body composition, hospitalisation and life quality. Tuberkuloz ve toraks, 64(2), 119–126.

https://doi.org/10.5578/tt.20998

Bass, C. M., Sajed, D. R., Adedipe, A. A., & West, T. E. (2015). Pulmonary ultrasound and pulse oximetry versus chest radiography and arterial blood gas analysis for the diagnosis of acute respiratory distress syndrome: A pilot study. Critical Care (London, England), 19(1), 282.

https://doi.org/10.1186/s13054-015-0995-5

Bollmeier, S. G., & Hartmann, A. P. (2020). Management of chronic obstructive pulmonary disease: A review focusing on exacerbations. American Journal of Health-System Pharmacy: AJHP: Official Journal of the American Society of Health-System Pharmacists, 77(4), 259–268.

https://doi.org/10.1093/ajhp/zxz306

Bucchieri, S., Alfano, P., Audino, P., Fazio, G., Marcantonio, S., & Cuttitta, G. (2022). Airway obstruction in primary care patients: Need for implementing spirometry use. Diagnostics 12(11).

https://doi.org/10.3390/diagnostics12112680

Calder, P. C., Bosco, N., Bourdet-Sicard, R., Capuron, L., Delzenne, N., Doré, J., Franceschi, C., Lehtinen, M. J., Recker, T., Salvioli, S., & Visioli, F. (2017). Health relevance of the modification of low-grade inflammation in ageing (inflammageing) and the role of nutrition. Ageing Research Reviews, 40, 95–119.

https://doi.org/10.1016/j.arr.2017.09.001

Chen, Y.-P., Chan, A. T. C., Le, Q.-T., Blanchard, P., Sun, Y., & Ma, J. (2019). Nasopharyngeal carcinoma. The Lancet, 394(10192), 64–80.

https://doi.org/10.1016/S0140-6736(19)30956-0

Collins, P. F., Yang, I. A., Chang, Y.-C., & Vaughan, A. (2019). Nutritional support in chronic obstructive pulmonary disease (COPD): an evidence update. Journal of Thoracic Disease, 11(S17), S2230–S2237.

https://doi.org/10.21037/jtd.2019.10.41

Dal Negro, R. W. (2019). COPD: The annual cost-of-illness during the last two decades in Italy, and its mortality predictivity power. Healthcare (Basel, Switzerland), 7(1), 35.

https://doi.org/10.3390/healthcare7010035

Demeyer, H., Donaire-Gonzalez, D., Gimeno-Santos, E., Ramon, M. A., DE Battle, J., Benet, M., Serra, I., Guerra, S., Farrero, E., Rodriguez, E., Ferrer, J., Sauleda, J., Monso, E., Gea, J., Rodriguez-Roisin, R., Agusti, A., Antó, J. M., & Garcia-Aymerich, J. (2019). Physical activity is associated with attenuated disease progression in chronic obstructive pulmonary disease. Medicine and Science in Sports and Exercise, 51(5), 833–840.

https://doi.org/10.1249/MSS.0000000000001859

Deslée, G., Mal, H., Dutau, H., Bourdin, A., Vergnon, J. M., Pison, C., Kessler, R., Jounieaux, V., Thiberville, L., Leroy, S., Marceau, A., Laroumagne, S., Mallet, J. P., Dukic, S., Barbe, C., Bulsei, J., Jolly, D., Durand-Zaleski, I., & Marquette, C. H. (2016). Lung volume reduction coil treatment vs usual care in patients with severe emphysema: The REVOLENS randomized clinical trial. JAMA, 315(2), 175–184.

https://doi.org/10.1001/jama.2015.17821

Devereux, G., Cotton, S., Fielding, S., McMeekin, N., Barnes, P. J., Briggs, A., Burns, G., Chaudhuri, R., Chrystyn, H., Davies, L., De Soyza, A., Gompertz, S., Haughney, J., Innes, K., Kaniewska, J., Lee, A., Morice, A., Norrie, J., Sullivan, A., … Price, D. (2018). Effect of theophylline as adjunct to inhaled corticosteroids on exacerbations in patients with COPD: A randomized clinical trial. JAMA, 320(15), 1548–1559.

https://doi.org/10.1001/jama.2018.14432

Di Marco, F., Sotgiu, G., Santus, P., O’Donnell, D. E., Beeh, K.-M., Dore, S., Roggi, M. A., Giuliani, L., Blasi, F., & Centanni, S. (2018). Long-acting bronchodilators improve exercise capacity in COPD patients: a systematic review and meta-analysis. Respiratory Research, 19(1), 18.

https://doi.org/10.1186/s12931-018-0721-3

Doo, J. H., Kim, S. M., Park, Y. J., Kim, K. H., Oh, Y. H., Kim, J. S., & Park, S. M. (2023). Smoking cessation after diagnosis of COPD is associated with lower all-cause and cause-specific mortality: a nationwide population-based cohort study of South Korean men. BMC Pulmonary Medicine, 23(1), 237.

https://doi.org/10.1186/s12890-023-02533-1

Dransfield, M. T., Kunisaki, K. M., Strand, M. J., Anzueto, A., Bhatt, S. P., Bowler, R. P., Criner, G. J., Curtis, J. L., Hanania, N. A., Nath, H., Putcha, N., Roark, S. E., Wan, E. S., Washko, G. R., Wells, J. M., Wendt, C. H., & Make, B. J. (2017). Acute exacerbations and lung function loss in smokers with and without chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine, 195(3), 324–330.

https://doi.org/10.1164/rccm.201605-1014OC

Dubé, B.-P., & Laveneziana, P. (2018). Effects of aging and comorbidities on nutritional status and muscle dysfunction in patients with COPD. Journal of Thoracic Disease, 10(S12), S1355–S1366.

https://doi.org/10.21037/jtd.2018.02.20

Fazleen, A., & Wilkinson, T. (2020). Early COPD: current evidence for diagnosis and management. Therapeutic Advances in Respiratory Disease, 14, 1753466620942128.

https://doi.org/10.1177/1753466620942128

Fekete, M., Csípő, T., Fazekas-Pongor, V., Fehér, Á., Szarvas, Z., Kaposvári, C., Horváth, K., Lehoczki, A., Tarantini, S., & Varga, J. T. (2023). The effectiveness of supplementation with key vitamins, minerals, antioxidants, and specific nutritional supplements in COPD-A review. Nutrients, 15(12).

https://doi.org/10.3390/nu15122741

Garnock-Jones, K. P. (2015). Roflumilast: A review in COPD. Drugs, 75(14), 1645–1656.

https://doi.org/10.1007/s40265-015-0463-1

Gea, J., Martínez-Llorens, J., & Barreiro, E. (2014). Nutritional abnormalities in chronic obstructive pulmonary disease. Medicina Clínica, 143(2), 78–84.

https://doi.org/10.1016/j.medcli.2013.05.040

Gea, J., Sancho-Muñoz, A., & Chalela, R. (2018). Nutritional status and muscle dysfunction in chronic respiratory diseases: stable phase versus acute exacerbations. Journal of Thoracic Disease, 10(S12), S1332–S1354.

https://doi.org/10.21037/jtd.2018.02.66

Gershon, A. S., Thiruchelvam, D., Chapman, K. R., Aaron, S. D., Stanbrook, M. B., Bourbeau, J., Tan, W., & To, T. (2018). Health services burden of undiagnosed and overdiagnosed COPD. Chest, 153(6), 1336–1346.

https://doi.org/10.1016/j.chest.2018.01.038

Global Initiative for Chronic Obstructive Lung Disease. (2022). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease.

https://goldcopd.org/wp-content/uploads/2021/12/GOLD-REPORT-2022-v1.1-22Nov2021_WMV.pdf

Hanania, N. A., & O’Donnell, D. E. (2019). Activity-related dyspnea in chronic obstructive pulmonary disease: physical and psychological consequences, unmet needs, and future directions. International Journal of Chronic Obstructive Pulmonary Disease, 14, 1127–1138.

https://doi.org/10.2147/COPD.S188141

He, Y., Qian, D. C., Diao, J. A., Cho, M. H., Silverman, E. K., Gusev, A., Manrai, A. K., Martin, A. R., & Patel, C. J. (2023). Prediction and stratification of longitudinal risk for chronic obstructive pulmonary disease across smoking behaviors. Nature Communications, 14(1), 8297.

https://doi.org/10.1038/s41467-023-44047-8

Hoshino, M., Ohtawa, J., & Akitsu, K. (2015). Comparison of airway dimensions with once daily tiotropium plus indacaterol versus twice daily Advair® in chronic obstructive pulmonary disease. Pulmonary Pharmacology & Therapeutics, 30, 128–133.

https://doi.org/10.1016/j.pupt.2014.08.002

Huckle, A. W., Fairclough, L. C., & Todd, I. (2018). Prophylactic antibiotic use in COPD and the potential anti-inflammatory activities of antibiotics. Respiratory Care, 63(5), 609–619.

https://doi.org/10.4187/respcare.05943

Ingadottir, A. R., Beck, A. M., Baldwin, C., Weekes, C. E., Geirsdottir, O. G., Ramel, A., Gislason, T., & Gunnarsdottir, I. (2018). Two components of the new ESPEN diagnostic criteria for malnutrition are independent predictors of lung function in hospitalized patients with chronic obstructive pulmonary disease (COPD). Clinical Nutrition (Edinburgh, Scotland), 37(4), 1323–1331.

https://doi.org/10.1016/j.clnu.2017.05.031

Janjua, S., Mathioudakis, A. G., Fortescue, R., Walker, R. A., Sharif, S., Threapleton, C. J., & Dias, S. (2021). Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis. The Cochrane Database of Systematic Reviews, 1(1), CD013198.

https://doi.org/10.1002/14651858.CD013198.pub2

Kaluza, J., Harris, H. R., Linden, A., & Wolk, A. (2018). Long-term consumption of fruits and vegetables and risk of chronic obstructive pulmonary disease: a prospective cohort study of women. International Journal of Epidemiology, 47(6), 1897–1909.

https://doi.org/10.1093/ije/dyy178

Kaluza, J., Larsson, S. C., Orsini, N., Linden, A., & Wolk, A. (2017). Fruit and vegetable consumption and risk of COPD: a prospective cohort study of men. Thorax, 72(6), 500–509.

https://doi.org/10.1136/thoraxjnl-2015-207851

Karpman, M. D., Eldridge, R., Follis, J. L., Etzel, C. J., Shete, S., & El-Zein, R. A. (2018). Chronic obstructive pulmonary disease among lung cancer-free smokers: The importance of healthy controls. Respiratory Investigation, 56(1), 28–33.

https://doi.org/10.1016/j.resinv.2017.11.002

Lee, I.-M., Shiroma, E. J., Kamada, M., Bassett, D. R., Matthews, C. E., & Buring, J. E. (2019). Association of step volume and intensity with all-cause mortality in older women. JAMA Internal Medicine, 179(8), 1105–1112.

https://doi.org/10.1001/jamainternmed.2019.0899

Maltais, F., Hamilton, A., Trampisch, M., Tafur, C., & Troosters, T. (2016). Effect of Once-daily tiotropium and olodaterol, alone and combined with exercise training, on two measures of walking capacity in patients with COPD. Chest, 150, 853A.

https://doi.org/10.1016/j.chest.2016.08.953

Marchetti, N., & Criner, G. J. (2015). Surgical approaches to treating emphysema: lung volume reduction surgery, bullectomy, and lung transplantation. Seminars in Respiratory and Critical Care Medicine, 36(4), 592–608.

https://doi.org/10.1055/s-0035-1556064

Mondello, P., Mian, M., Aloisi, C., Famà, F., Mondello, S., & Pitini, V. (2015). Cancer cachexia syndrome: pathogenesis, diagnosis, and new therapeutic options. Nutrition and Cancer, 67(1), 12–26.

https://doi.org/10.1080/01635581.2015.976318

Murgia, N., & Gambelunghe, A. (2022). Occupational COPD-The most under-recognized occupational lung disease? Respirology (Carlton, Vic.), 27(6), 399–410.

https://doi.org/10.1111/resp.14272

Murphy, P. B., Rehal, S., Arbane, G., Bourke, S., Calverley, P. M. A., Crook, A. M., Dowson, L., Duffy, N., Gibson, G. J., Hughes, P. D., Hurst, J. R., Lewis, K. E., Mukherjee, R., Nickol, A., Oscroft, N., Patout, M., Pepperell, J., Smith, I., Stradling, J. R., … Hart, N. (2017). Effect of home noninvasive ventilation with oxygen therapy vs oxygen therapy alone on hospital readmission or death after an acute COPD exacerbation: a randomized clinical trial. JAMA, 317(21), 2177–2186.

https://doi.org/10.1001/jama.2017.4451

Pavord, I. D., Lettis, S., Locantore, N., Pascoe, S., Jones, P. W., Wedzicha, J. A., & Barnes, N. C. (2016). Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD. Thorax, 71(2), 118–125.

https://doi.org/10.1136/thoraxjnl-2015-207021

Perez-Padilla, R., Wehrmeister, F. C., Montes de Oca, M., Lopez, M. V., Jardim, J. R., Muino, A., Valdivia, G., Pertuze, J., & Menezes, A. M. B. (2015). Instability in the COPD diagnosis upon repeat testing vary with the definition of COPD. PloS One, 10(3), e0121832.

https://doi.org/10.1371/journal.pone.0121832

Putcha, N., & Wise, R. A. (2018). Medication regimens for managing COPD exacerbations. Respiratory Care, 63(6), 773–782.

https://doi.org/10.4187/respcare.05912

Saadeh, C., Saadeh, C., Cross, B., Gaylor, M., & Griffith, M. (2015). Advantage of impulse oscillometry over spirometry to diagnose chronic obstructive pulmonary disease and monitor pulmonary responses to bronchodilators: An observational study. SAGE Open Medicine, 3, 2050312115578957.

https://doi.org/10.1177/2050312115578957

Saeed, M. I., Sivapalan, P., Eklöf, J., Ulrik, C. S., Pisinger, C., Lapperre, T., Tønnesen, P., Hoyer, N., Janner, J., Karlsson, M. L., Bech, C. S., Marså, K., Godtfredsen, N., Brøndum, E., Munk, B., Raaschou, M., Browatzski, A., Lütken, P., & Jensen, J.-U. S. (2020). TOB-STOP-COP (TOBacco STOP in COPd trial): study protocol—a randomized open-label, superiority, multicenter, two-arm intervention study of the effect of “high-intensity” vs. “low-intensity” smoking cessation intervention in active smokers with chronic obstructive pulmonary disease. Trials, 21(1), 730.

https://doi.org/10.1186/s13063-020-04653-z

Safiri, S., Carson-Chahhoud, K., Noori, M., Nejadghaderi, S. A., Sullman, M. J. M., Ahmadian Heris, J., Ansarin, K., Mansournia, M. A., Collins, G. S., Kolahi, A.-A., & Kaufman, J. S. (2022). Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019. BMJ (Clinical Research Ed.), 378, e069679.

https://doi.org/10.1136/bmj-2021-069679

Sarkar, M., Bhardwaz, R., Madabhavi, I., & Modi, M. (2019). Physical signs in patients with chronic obstructive pulmonary disease. Lung India: Official Organ of Indian Chest Society, 36(1), 38–47.

https://doi.org/10.4103/lungindia.lungindia_145_18

Siddiqui, F. M., & Diamond, J. M. (2018). Lung transplantation for chronic obstructive pulmonary disease: past, present, and future directions. Current Opinion in Pulmonary Medicine, 24(2), 199–204.

https://doi.org/10.1097/MCP.0000000000000452

Singh, G., Zhang, W., Kuo, Y.-F., & Sharma, G. (2016). Association of psychological disorders with 30-day readmission rates in patients with COPD. Chest, 149(4), 905–915.

https://doi.org/10.1378/chest.15-0449

Singh Thakur, J., Nangia, R., & Singh, S. (2021). Progress and challenges in achieving noncommunicable diseases targets for the sustainable development goals. FASEB BioAdvances, 3(8), 563–568.

https://doi.org/10.1096/fba.2020-00117

Sorge, R., & DeBlieux, P. (2020). Acute exacerbations of chronic obstructive pulmonary disease: A primer for emergency physicians. The Journal of Emergency Medicine, 59(5), 643–659.

https://doi.org/10.1016/j.jemermed.2020.07.001

Strzelak, A., Ratajczak, A., Adamiec, A., & Feleszko, W. (2018). Tobacco smoke induces and alters immune responses in the lung triggering inflammation, allergy, asthma and other lung diseases: A mechanistic review. International Journal of Environmental Research and Public Health, 15(5).

https://doi.org/10.3390/ijerph15051033

Szmidt, M. K., Kaluza, J., Harris, H. R., Linden, A., & Wolk, A. (2020). Long-term dietary fiber intake and risk of chronic obstructive pulmonary disease: a prospective cohort study of women. European Journal of Nutrition, 59(5), 1869–1879.

https://doi.org/10.1007/s00394-019-02038-w

Troosters, T., Maltais, F., Leidy, N., Lavoie, K. L., Sedeno, M., Janssens, W., Garcia-Aymerich, J., Erzen, D., De Sousa, D., Korducki, L., Hamilton, A., & Bourbeau, J. (2018). Effect of bronchodilation, exercise training, and behavior modification on symptoms and physical activity in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine, 198(8), 1021–1032.

https://doi.org/10.1164/rccm.201706-1288OC

US Food and Drug Administration. (2021). Sublocade (buprenorphine extended‐release) injection, for subcutaneous use.

https://www.accessdata.fda.gov/Drugsatfda_docs/Label/2021/209819s018lbl.Pdf#page=45

van Dort, M. J., Romme, E. A. P. M., Smeenk, F. W. J. M., Geusens, P. P. P. M., Wouters, E. F. M., & van den Bergh, J. P. (2018). Diagnosis of vertebral deformities on chest CT and DXA compared to routine lateral thoracic spine X-ray. Osteoporosis International: A Journal Established as Result of Cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 29(6), 1285–1293.

https://doi.org/10.1007/s00198-018-4412-1

van Iersel, L. E. J., Beijers, R. J. H. C. G., Gosker, H. R., & Schols, A. M. W. J. (2022). Nutrition as a modifiable factor in the onset and progression of pulmonary function impairment in COPD: a systematic review. Nutrition Reviews, 80(6), 1434–1444.

https://doi.org/10.1093/nutrit/nuab077

Vogelmeier, C. F., Criner, G. J., Martinez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., Frith, P., Halpin, D. M. G., López Varela, M. V., Nishimura, M., Roche, N., Rodriguez-Roisin, R., Sin, D. D., Singh, D., Stockley, R., … Agusti, A. (2017). Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: gold executive summary. The European Respiratory Journal, 49(3).

https://doi.org/10.1183/13993003.00214-2017

Wada, H., Ikeda, A., Maruyama, K., Yamagishi, K., Barnes, P. J., Tanigawa, T., Tamakoshi, A., & Iso, H. (2021). Low BMI and weight loss aggravate COPD mortality in men, findings from a large perspective cohort: the JACC study. Scientific Reports, 11(1), 1531.

https://doi.org/10.1038/s41598-020-79860-4

Wedzicha, J. A. E. C.-C., Miravitlles, M., Hurst, J. R., Calverley, P. M. A., Albert, R. K., Anzueto, A., Criner, G. J., Papi, A., Rabe, K. F., Rigau, D., Sliwinski, P., Tonia, T., Vestbo, J., Wilson, K. C., & Krishnan, J. A. A. C.-C. (2017). Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline. The European Respiratory Journal, 49(3).

https://doi.org/10.1183/13993003.00791-2016

Wetherbee, E. E., Niewoehner, D. E., Sisson, J. H., Lindberg, S. M., Connett, J. E., & Kunisaki, K. M. (2015). Self-reported alcohol intake and risk of acute exacerbations of chronic obstructive pulmonary disease: a prospective cohort study. International Journal of Chronic Obstructive Pulmonary Disease, 10, 1363–1370.

https://doi.org/10.2147/COPD.S86572

Williams, D. M., & Rubin, B. K. (2018). Clinical Pharmacology of bronchodilator medications. Respiratory Care, 63(6), 641–654.

https://doi.org/10.4187/respcare.06051

Zhai, H., Wang, Y., & Jiang, W. (2020). Fruit and vegetable intake and the risk of chronic obstructive pulmonary disease: a dose-response meta-analysis of observational studies. BioMed Research International, 2020, 3783481.

https://doi.org/10.1155/2020/3783481

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2024 Array